Osama Sabri Selected Research

N-acetyltalosaminuronic acid (NAT)

10/2022	Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.
11/2021	Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity.
1/2021	Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuits.
1/2020	Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.
1/2019	Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
1/2018	Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.
6/2017	Central noradrenaline transporter availability in highly obese, non-depressed individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osama Sabri Research Topics

Disease

49	Alzheimer Disease (Alzheimer's Disease) 07/2023 - 11/2003
36	Dementia (Dementias) 01/2022 - 03/2008
22	Cognitive Dysfunction 01/2022 - 03/2008
16	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 03/2006
13	Obesity 11/2023 - 01/2013
9	Neoplasms (Cancer) 01/2024 - 04/2003
9	Atrophy 07/2023 - 01/2013
8	Parkinson Disease (Parkinson's Disease) 02/2021 - 05/2004
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2017 - 06/2010
7	Amyloid Plaque 11/2017 - 04/2006
6	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 08/2006
5	Tauopathies 02/2024 - 01/2019
5	Weight Loss (Weight Reduction) 10/2022 - 01/2016
4	Disease Progression 01/2024 - 01/2018
4	Body Weight (Weight, Body) 10/2022 - 01/2016
4	Hypoxia (Hypoxemia) 01/2019 - 04/2003
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2011 - 08/2004
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023 - 11/2020
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2022 - 02/2009
3	Lymphoma (Lymphomas) 09/2021 - 01/2021
3	Corticobasal Degeneration 05/2021 - 01/2017
3	Neurobehavioral Manifestations 01/2021 - 08/2015
3	Pulmonary Hypertension 01/2021 - 01/2005
3	Multiple Sclerosis 01/2021 - 05/2014
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2015
3	Death (Near-Death Experience) 01/2017 - 06/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023 - 01/2021
2	Neuroinflammatory Diseases 07/2023 - 04/2015
2	Morbid Obesity 11/2021 - 01/2017
2	Hyperthyroidism 01/2021 - 12/2016
2	Fatigue 01/2021 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2021
2	Movement Disorders (Movement Disorder) 07/2019 - 08/2008
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 05/2015
2	Hyperphagia (Overeating) 06/2017 - 01/2013
2	Parkinsonian Disorders (Parkinsonism) 07/2016 - 01/2013
2	Depressive Disorder (Melancholia) 09/2015 - 08/2009
2	Glioma (Gliomas) 08/2014 - 01/2008
2	Hepatolenticular Degeneration (Wilson's Disease) 04/2012 - 08/2002
2	Thyroid Diseases (Thyroid Disease) 04/2009 - 08/2005
2	Myocardial Infarction 10/2005 - 03/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2005 - 03/2004
2	Stroke (Strokes) 01/2005 - 03/2004
1	Retroperitoneal liposarcoma 05/2024
1	Clinical Deterioration 01/2024
1	Pheochromocytoma 01/2024
1	Paraganglioma (Paragangliomas) 01/2024
1	Binge-Eating Disorder (Binge Eating Disorder) 11/2023

Drug/Important Bio-Agent (IBA)

39	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2011
29	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2011
18	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2023 - 01/2011
15	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2005
14	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 04/2008
11	Serotonin (5 Hydroxytryptamine)IBA 01/2024 - 11/2003
10	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2023 - 08/2004
9	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2022 - 03/2006
8	Amyloid beta-PeptidesIBA 01/2022 - 04/2006
7	N-acetyltalosaminuronic acid (NAT)IBA 10/2022 - 06/2017
7	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 10/2022 - 01/2018
7	Cholinergic Agents (Cholinergics)IBA 01/2022 - 11/2003
6	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2024 - 11/2003
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2021 - 10/2005
5	fluoronorchloroepibatidineIBA 12/2022 - 04/2013
4	LigandsIBA 01/2023 - 03/2008
4	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2011
4	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 02/2021 - 02/2009
4	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 01/2006 - 08/2002
3	Dopamine (Intropin)FDA LinkGeneric 02/2024 - 01/2013
3	tau Proteins (tau Protein)IBA 01/2022 - 01/2019
3	Deoxyglucose (2 Deoxy D glucose)IBA 09/2021 - 10/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2019
3	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 11/2003
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2024 - 01/2006
2	Chimeric Antigen ReceptorsIBA 08/2023 - 01/2021
2	Cholinergic ReceptorsIBA 01/2022 - 03/2008
2	PrionsIBA 01/2022 - 07/2019
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2021 - 12/2020
2	1'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA 01/2021 - 05/2020
2	Tumor Suppressor Protein p53IBA 01/2019 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2019
2	Citalopram FDA LinkGeneric 01/2019 - 01/2006
2	Indicators and Reagents (Reagents)IBA 07/2017 - 08/2015
2	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 08/2008 - 02/2003
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2008 - 10/2005
2	2-fluoro-3-(2-azetidinylmethoxy)pyridineIBA 03/2008 - 03/2008
1	Technetium Tc 99m Dimercaptosuccinic AcidIBA 05/2024
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2024
1	3-methoxytyramine (methoxytyramine)IBA 01/2024
1	NormetanephrineIBA 01/2024
1	axicabtagene ciloleucelIBA 08/2023

Therapy/Procedure

12	Therapeutics 07/2022 - 07/2005
7	Drug Therapy (Chemotherapy) 01/2021 - 08/2006
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2022 - 11/2021
2	Deep Brain Stimulation 02/2021 - 07/2008
2	Transplantation 01/2021 - 10/2005
2	Induction Chemotherapy 10/2018 - 01/2017
2	Radiotherapy 01/2017 - 01/2008
2	Bariatric Surgery 01/2017 - 01/2016
1	Precision Medicine 11/2023